Oxymatrine inhibits invasion and metastasis of triple-negative breast cancer cells by regulating epithelial mesenchymal transition

doi:10.12092/j.issn.1009-2501.2018.01.003

Abstract

Abstract:

AIM: To study the inhibitory effects of oxymatrine on growth and migration of human triple-negative breast cancer MDA-MB-231 cell. METHODS: CCK-8 assay was used to detect the inhibitory effects of oxymatrine on the growth of MDA-MB-231 cells. Inhibitory effect of oxymatrine on cell cycle of MDA-MB-231 cells was detected by flow cytometry (FCM). Effect of oxymatrine on migration of MDA-MB-231 cells was detected by scratch experimental. RESULTS: Compared with the control group, the growth of MDA-MB-231 cells decreased significantly in a time- and dose-dependent manner after oxymatrine treatment (2, 4, 6, 8, 10, 20 mg/mL for 24, 48 and 72 h). Oxymatrine significantly increased the number of cells in G0/G1 phase and decreased the number of cells in S and G2/M phase（P<0.05）. Transwell showed that oxymatrine treated MDA-MB-231 cells for 12 h significantly inhibited the invasion of MDA-MB-231. The high concentration of oxymatrine significantly up-regulated the expression of E-cadherin and inhibited the expression of Snail-2 mRNA (P<0.01). CONCLUSION: Oxymatrine exerts its antitumor effect by inhibiting the growth and invasion of MDA-MB-231 cells, which plays a potential role on anti-tumor growth and metastasis.

Key words: oxymatrine, triple-negative breast cancer cells, EMT, migration, growth inhibition

CLC Number:

CAI Jiaqin, WEI Xiaoxia, HUANG Xuhui, ZHUANG Jie, SUN Hong. Oxymatrine inhibits invasion and metastasis of triple-negative breast cancer cells by regulating epithelial mesenchymal transition[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(1): 13-17.

References

［1］李屹, 张丽楠, 杨磊.苦参碱药理作用研究进展［J］.实用中医药杂志，2012，28（5）：423-424.
［2］刘益均，郑军，肖文波，等．氧化苦参碱对人胃癌SGC-7901细胞增殖及血管内皮生长因子表达的影响［J］.中国癌症杂志，2010，20（1）：22-26.
［3］徐邦牢, 李坚．苦参碱对肝癌细胞增殖抑制作用研究［J］．临床医学工程，2010,17(12):3-4.
［4］张琼，潘平东．氧化苦参碱对人卵巢癌HO-8910细胞的作用及其机制的初步研究［J］．医学信息,2010,23(9):3381-3383.
［5］Qi L, Xiao X, Xuyong W, et al. Oxymatrine induces human pancreatic cancer PANC-1 cells apoptosis via regulating expression of Bcl-2 and IAP families, and releasing of cytochrome c［J］.J Exp Clin Cancer Res,2011,30(1):66-72.
［6］夏宝妹, 周怀君, 胡娅莉, 等. 氧化苦参碱对子宫内膜癌细胞中血管内皮生长因子表达的抑制作用及其机制［J］.中华妇产科杂志, 2009, 44(5): 388-390.
［7］李索妮，姚煜，南克俊. 三阴性乳腺癌治疗进展［J］. 现代肿瘤医学，2014，22（1）：197-200.
［8］张英，祁鑫，朱小云,等. 氧化苦参碱对人乳腺癌MCF-7细胞的生长抑制作用及其机制研究［J］. 现代肿瘤医学,2014,22(3):494-497.
［9］周炳刚,孙靖中,范玉琢,等.氧化苦参碱诱导人乳腺癌细胞MCF-7凋亡的实验研究［J］.中国药理学通报，2001，18（6）：689-691.
［10］Laurentiis MD, Cianniello D, Caputo R, et al. Treatment of triple negative breast cancer (TNBC): current options and future perspectives［J］. Cancer Treat Rev, 2010,36(3):S80-S86.
［11］摆茹，杨伟. 氧化苦参碱对肝癌细胞QGY-7703迁移侵袭能力和MMP-9表达的影响［J］. 宁夏医科大学学报，2012,34(12):1243-1245.
［12］李飞，谢立群，冀润利，等. 氧化苦参碱对人胰腺癌细胞株SWl990侵袭转移能力的影响［J］.中华胰腺病杂志，2011,11(3):176-179.
［13］Nieto MA. The ins and outs of the epithelial to mesenchymal transition in health and disease［J］. Annu Rev Cell Dev Biol, 2011, 27(1):347-376.
［14］Thiery JP, Acloque H, Huang RY. Epithelial-mesenchymal transitions in development and disease［J］. Cell, 2009, 139(5): 871-890.
［15］Scanlon CS, van Tubergen EA, Inglehart RC, et al. Biomarkers of epithelial-mesenchymal transition in squamous cell carcinoma［J］. J Dent Res,2013,92(2):114-121.
［16］Turley EA, Veiseh M, Radisky DC, et al. Mechanisms of disease: Epithelial-mesenchymal transition-does cellular plasticity fuel neoplastic progression［J］. Nat Clin Pract Oncol, 2008, 5(5): 280-290.

[1]	WANG Yan, ZHANG Jinhui, ZHAO Yongchen, LIU Hongxiang, LIU Yawei, MIAO Huanhuan, YANG Xincai. Sequoiaflavone inhibits stem cell properties such as proliferation and invasion of gastric cancer cells by down-regulating PI3K/AKT signaling pathway [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(5): 508-513.
[2]	SUI Yuxia, ZHUANG Jie, ZHUANG Min, HUANG Gui. Delicaflavone inhibits the invasion and migration of gefitinib-resistant lung cancer PC-9/GR cells by regulating epithelial-mesenchymal transition via PI3K/Akt/mTOR pathway [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(6): 614-621.
[3]	LI Yanyan, FANG Xiaojie, YIN Xin, SUN Xi, RAO Chunhui. circZNF124 regulates the proliferation, migration and invasion of colorectal cancer SW620 cells by targeting miR-4262 [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(11): 1231-1239.
[4]	ZHOU Shiqin, LUO Yali, ZHOU Wen, Qi Xiaofeng, XIAO Mengyong. Molecular mechanism and treatment of pulmonary fibrosis [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(10): 1133-1147.
[5]	JIANG Yuhua, ZHI Hui, LU Linming, TIAN Dahao, WANG Xiaoqing, GE Yu, XIE Shangfu, WANG Qi. AHVAC-I reverses tumor growth of cancer-associated fibroblasats in gastric cancer [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(4): 389-394.
[6]	CHEN Linjun, CHEN Wenbin. Jolkinolide B inhibits the proliferation and metastasis of colon cancer cells via blocking PI3K/Akt/NF-κB pathway [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(3): 250-257.
[7]	HUANG Kang, LI Ling, YE Qifa, PENG Guizhu. Expression of long non-coding RNA LINC00844 in hepatocellular carcinoma and its inhibiting effect on cell proliferation and migration [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(4): 366-372.
[8]	SHEN Cheng, YANG Nianzhao, WANG Minghai, WU Lisheng, ZHU Zhiqiang. Inhibiting RNA methylase NSUN2 reduce the invasion and migration of gastric cancer cell [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(4): 380-386.
[9]	PAN Yalan, YUAN Wenchao, MA Yong, GUO Yang, ZHENG Suyang, XU Guihua, LIU Jiahuan. Effect of JiSuiKang on the microglia infiltration and neuron survival in the spinal cord injury area of rats [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(2): 151-158.
[10]	NIE Juan，CAO Yumei，YANG Dongmei，SUN Siyu，WANG Qiaoqiong, XIE Xuejiao, TUO Qinhui. Roles of Prunella vulgaris L. in the proliferation and migration of vascular smooth muscle cells and its molecular mechanisms [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(9): 977-982.
[11]	WANG Qingwei, DING Jin, LV Yuanyuan, LUO Xianchen, NI Guantai. Effects of PHA-767491 on the inhibition of CDC-7 expression in endometrial cancer ishikawa cell line [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(8): 866-871.
[12]	BAO Jing，LI Xiaofeng，ZHANG Hanshuo，XU Qingqing，MENG Xiaoming，HUANG Cheng，LI Jun. Role of RAB32 on proliferation and migration of chronic myeloid leukemia K562 cells [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(12): 1321-1327.
[13]	LI Yuqin, WANG Kai, AO Li, LU Xiaolan, SHI Jianping. miR-142-5p inhibits proliferation and migration of gastric cancer cells through DNMT1 [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(12): 1328-1334.
[14]	QIAN Wanfeng, WANG Xiufeng, CHEN Xuepeng. Expression of miR-19b in osteosarcoma and its effect on invasion and migration of osteosarcoma Saos-2 cells by regulating KLF13 [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(11): 1242-1248.
[15]	LI Jinyu, HUANG Danmei, ZHANG Yanmei, SHI Ganggang, WANG Bin. Macrophage migration inhibitory factor protects H9c2 cardiac myocytes against hypoxia/reoxygenation injury through regulation of autophagy [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(5): 531-535.